¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reaction substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • allergic reaction
    ¾Ë·¹¸£±â¹ÝÀÀ
  • allograft reaction
    µ¿Á¾À̽ĹÝÀÀ
  • alternative reaction
    ±³´ë¹ÝÀÀ
  • anamnestic reaction
    ¸é¿ª±â¾ï¹ÝÀÀ
  • anaphylactic reaction
    ¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, Ãʰú¹Î¹ÝÀÀ
  • anaphylactoid reaction
    À¯»ç¾Æ³ªÇʶô½Ã½º¹ÝÀÀ, À¯»çÃʰú¹Î¹ÝÀÀ
  • bimolecular reaction
    À̺ÐÀÚ¹ÝÀÀ
  • biologic false positive reaction
    »ý¹°ÇÐÀû°ÅÁþ¾ç¼º¹ÝÀÀ
  • biphasic reaction
    À̻󼺹ÝÀÀ
  • bisubstrate reaction
    µÎ±âÁú¹ÝÀÀ
  • biuret reaction
    ºä·¿¹ÝÀÀ
  • blanching reaction
    â¹é¹ÝÀÀ
  • blood transfusion reaction
    ¼öÇ÷¹ÝÀÀ
  • body-righting reaction
    ¸ö¹Ù·ÎÀâ±â¹ÝÀÀ, Á¤Çâ¹ÝÀÀ
  • cadaveric reaction
    ½Ãü¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • sleep-promoting substance
    ¼ö¸éÁõÁø¹°Áú
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • specific soluble substance
    ƯÀ̰¡¿ë¹°Áú
  • spongy substance
    ÇØ¸éÁú
  • subacrosomal substance
    ÷´Üü¹Ø¹°Áú
  • substance withdrawal
    ¹°Áú±Ý´Ü
  • threshold substance
    ¹®Åΰª¹°Áú, ¿ªÄ¡¹°Áú
  • toxic substance
    µ¶¼º¹°Áú
  • transforming substance
    ÇüÁúÀüȯÀ¯È¿¹°Áú
  • visual substance
    ½Ã°¢¹°Áú
  • volatile substance
    Èֹ߹°Áú
  • white substance
    ¹é»öÁú
  • zymoplastic substance
    ÀÀÇ÷ÃËÁø¹°Áú
  • acrosome reaction
    ÷´Üü¹ÝÀÀ
  • activator reaction
    Ȱ¼ºÁ¦¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Medina-Ramirez reaction
    ¸Þµð³ª-¶ó¹Ì·¹Áî ¹ÝÀÀ
  • Mitsuda reaction
    ¹ÌÂê´Ù¹ÝÀÀ
  • Neill-Mooser reaction
    ´Ò-¹«Àú ¹ßÁø¿­°Ë»ç
  • PAS reaction ; periodic acld schiff r
    PAS ¹ÝÀÀ<¿°»ö>.
  • PCR(polymerase chain reaction)
    ÁßÇÕ¿¬¼â¹ÝÀÀ
  • Porter Silber reaction
    Æ÷ÅÍ-½Ç¹ö ¹ÝÀÀ
  • Prausnitz-K*stner (PK) reaction
    ÇÁ¶ó¿ì½º´ÏÃ÷-Ä¿½ºÆ®³Ê¹ÝÀÀ (PK¹ÝÀÀ, Á¦1Çü °ú¹Î¹ÝÀÀ Àü´Þ½Ã
  • Prausnitz-Kustner(P-K) reaction
    ÇÁ¶ó¿ì½º´ÏÃ÷ Äû½ºÆ®³Ê ¹ÝÀÀ
  • Quellung reaction
    Çù¸·ÆØÃ¢¹ÝÀÀ
  • Quellung reaction
    Çù¸·ÆØÃ¢½ÃÇè
  • Rivalta s reaction
    ¸®¹ßŸ¹ÝÀÀ.
  • Romers reaction
    ·Ú¸Ó¹ÝÀÀ (°áÇÙ±Õ°¨¿° ±â´ÏÇȹÝÀÀ, ÄÚÈ£Çö»ó°ú À¯»ç)
  • Sanarelli-Shwartzman reaction
    »ç³ª·¼¸®-½´¹ßÂ길¹ÝÀÀ
  • Schultz-Charton reaction = Schultz-Charton test
    ½¶Ã÷ Įư ¹ÝÀÀ
  • Schwartzmann reaction = Schwartzmann phenomenon
    ½´¹Ù¸£Ã÷¸¸ ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • lens substance
    ¼öÁ¤Ã¼Áú(¡­òõ).
  • lens substance
    ¼öÁ¤Ã¼¹°Áú
  • melanophore expanding substance
    Èæ»ö¼¼Æ÷È®Àå¹°Áú(¡­á¬øàüªíåÚªòõ).
  • metachromatic substance
    ÀÌ¿°¼º ¹°Áú(ì¶æøàõÚªòõ).
  • molecular substance
    ºÐÀÚ¹°Áú(¡­Úªòõ).
  • muscular substance
    ±ÙÀ°(ÐÉë¿), ±Ù(ÐÉ).
  • muscular substance
    ±ÙÀ°Áú
  • nerve transmitter substance =neurotransmitte r
    ½Å°æÀü´Þ¹°Áú(~îîÓ¹Úªòõ).
  • nerve transmitter substance =neurotransmitter
    ½Å°æÀü´Þ¹°Áú(~îîÓ¹Úªòõ).
  • neurosecretory substance
    ½Å°æºÐºñ¹°
  • neurotransmitter =nerve transmitter substance
    ½Å°æÀü´Þ¹°Áú.
  • neurotransmitter [=nerve transmitter substance]
    ½Å°æÀü´Þ¹°Áú
  • odoriferous substance
    Çâ·á(úÅè÷).
  • osteoid substance
    Dz»À¹°Áú
  • oxytocic substance
    ÀڱüöÃ༺ ¹°Áú.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • formation reaction
    Çü¼º ¹ÝÀÀ(û¡à÷Úãëë)
  • formose reaction
    Æ÷¸£¸ð½º ¹ÝÀÀ(Úãëë)
  • fragmentation reaction
    Á¶°¢³»±â ¹ÝÀÀ(Úãëë)
  • fragment reaction
    Á¶°¢ ¹ÝÀÀ(Úãëë)
  • glyoxylic acid reaction
    ±Û¶óÀÌ¿Á½Ç»ê(ß«) ¹ÝÀÀ(Úãëë)
  • group transfer reaction
    ¿øÀÚ´Ü ÀüÀÌ ¹ÝÀÀ(ê«í­Ó¥ï®ì¹Úãëë)
  • half-reaction
    ¹Ý¹ÝÀÀ(ÚâÚãëë)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
  • Hill reaction
    Èú ¹ÝÀÀ(Úãëë)
  • Hopkins-Cole reaction
    ȩŲ½º-ÄÝ ¹ÝÀÀ(Úãëë)
  • idling reaction
    À¯ÇÑ ¹ÝÀÀ(ë´ùØÚãëë)
  • immune reaction
    ¸é¿ª ¹ÝÀÀ(Øóæ¹Úãëë)
  • irreversible reaction
    ºñ°¡¿ª ¹ÝÀÀ(ުʦæ½Úãëë)
  • Liebermann-Burchard reaction
    ¸®¹ö¸¸-¹öÄ«µå¹ÝÀÀ(Úãëë)
  • light reaction
    ±¤¹ÝÀÀ(ÎÃÚãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ADS acute death syndrome; acute diarrheal syndrome; Alcohol Dependence Scale; alternative delivery syste...
ALS acute lateral sclerosis; advanced life support; afferent loop syndrome; amyotrophic lateral sclerosi...
AMS ablepharon-microstomia syndrome; acute mountain sickness; adenosylmethionine synthetase; aggravated ...
ams amount of a substance
ANAS anastomosis; auditory nerve activating substance
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SP-IR Substance P immunoreactive
SP-IR Substance P immunoreactivity
SPLI Substance P like immunoreactivity
SPR Substance P receptor
SP-LI Substance P-like immunoreactive
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • catalytic reaction
    Ã˸йÝÀÀ
    Ã˸ŠÀÛ¿ë¿¡ ÀÇÇØ¼­ È­Çй°ÁúÀÇ ÀÛ¿ëÀ¸·Î ÀϾ´Â Çö»ó.
  • cell mediated reaction
    ¼¼Æ÷ ¸Å°³¼º ¹ÝÀÀ
  • cessation reaction
    Á¤Áö ¹ÝÀÀ
  • chain initiation reaction
    ¿¬¼â °³½Ã ¹ÝÀÀ
  • conjugating reaction
    °áÇÕ ¹ÝÀÀ
  • conjunctival reaction
    °á¸· ¹ÝÀÀ
  • cross reaction
    ±³Â÷ ¹ÝÀÀ
    Ç׿ø Ç×ü ¹ÝÀÀÀÇ °¡Àå Å« Ư¡Àº ÀÌ ¹ÝÀÀÀÌ Æ¯ÀÌÀûÀ̶ó´Â °ÍÀε¥ ¶§·Î´Â ÀÌ ¿øÄ¢¿¡ ¸ÂÁö ¾Ê´Â ¹ÝÀÀÀ» º¸ÀÌ°Ô µÇ´Â ¼ö°¡ ÀÖ´Ù. ¿¹¸¦ µé¾î ¼ÒÀÇ Ç÷û ¾ËºÎ¹Î¿¡ ´ëÇÑ Ç×ü´Â ¾çÀÇ Ç÷û ¾ËºÎ¹Î°úµµ ¾î´À Á¤µµ ¹ÝÀÀÇϴµ¥ ÀÌ °°Àº ¹ÝÀÀÀ» ±³Â÷ ¹ÝÀÀÀ̶ó ÇÑ´Ù.
  • cutaneous reaction
    ÇǺΠ¹ÝÀÀ
  • Dakin-West`s reaction
    µ¥ÀÌŲ-¿þ½ºÆ® ¹ÝÀÀ
  • Dakin`s reaction
    µ¥ÀÌŲ ¹ÝÀÀ
  • delayed reaction
    Áö¿¬ ¹ÝÀÀ
  • depressive reaction
    ¿ì¿ï ¹ÝÀÀ
  • desmoid reaction
    Àδë¾ç ¹ÝÀÀ
  • donor reaction
    °øÇ÷ÀÚ ¹ÝÀÀ
  • emergency reaction
    ±ä±Þ ¹ÝÀÀ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
ergastic substance Metabolically inert products of photosynthesis, such as starch grains and fat globules.
(18 Nov 1997)
exophthalmos-producing substance A factor found in crude extract of pituitary tissue that produced exophthalmos in laboratory animals (especially fish). Its existence and role in producing exophthalmopathy in Graves' disease is questioned.
(05 Mar 2000)
Kendall's substance A group of corticosteroids. Kendall's compound A (11-dehydrocorticosterone); Kendall's compound B (corticosterone); Kendall's compound E (cortisone); Kendall's compound F (cortisol).
Synonym: Kendall's substance.
(05 Mar 2000)
united states substance abuse and mental health services administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym samhsa. On 1 october 1992, the united states alcohol, drug abuse, and mental health administration (adamha) became samhsa. (telephone communication with samhsa 7 april 1992)
(12 Dec 1998)
zymoplastic substance <haematology> Traditional name for substance in plasma that converts prothrombin to thrombin. Now known not to be a single substance. (See thrombin).
(18 Nov 1997)
filar substance A filamentous plasmatic material, beaded with granules, demonstrable by means of vital staining in the immature red blood cells.
Synonym: alpha substance, filar mass, filar substance, substantia reticularis, substantia reticulofilamentosa.
Synonym: reticular formation.
(05 Mar 2000)
accelerated reaction A response occurring in a shorter time than expected; the cutaneous manifestations occurring during the period between the second and tenth day following smallpox vaccination; because it is intermediate between a primary reaction and an immediate reaction, it is regarded as evidence of some degree of resistance.
Synonym: vaccinoid reaction.
(05 Mar 2000)
acid reaction Any test by which an acid reaction is recognised such as the change of blue litmus paper to red, an excess of hydrogen ions over hydroxide ions in aqueous solution indicated by a pH value less than 7 (at 22°C).
Compare: dissociation constant of water.
(05 Mar 2000)
acute-phase reaction <immunology, rheumatology> Refers to the changes in synthesis of certain proteins within the serum during an inflammatory response, which provides rapid protection for the host against microorganisms via non-specific defense mechanisms.
It consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors.
(12 Jul 2000)
acute situational reaction An acute emotional reaction related to extreme environmental stress.
Synonym: acute situational reaction.
(05 Mar 2000)
acute stress reaction A sudden bout of anxiety that is often accompanied by the features of hyperventilation (tingling around mouth and in fingertips, rapid breathing, faintness or fainting).
(27 Sep 1997)
addition reaction <chemistry> Any reaction in which two chemicals combine to form a single chemical.
(15 Jan 1998)
adverse drug reaction reporting systems Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.
(12 Dec 1998)
adverse reaction Any undesirable or unwanted consequence of a preventive, diagnostic, or therapeutic procedure or regimen.
(05 Mar 2000)
agar-gel reaction <immunology> The reaction between an antibody and an antigen during an immunology lab procedure where the two are allowed to diffuse toward each other through an agar-gel medium.
Lines of precipitation form in the places on the gel where the two react with each other and shows where the reaction has occurred.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á